术前化疗在晚期卵巢癌综合治疗中的价值

• 作 者: 吴铭
• 机 构: 兴化市第三人民医院肿瘤科,
• 出 处: 江苏医药
• 发表日期: 2012年15期
• 关键词: 晚期卵巢癌 术前化疗 腹腔种植转移 肿瘤细胞减灭术 卵巢 上皮性卵巢癌 居第 肿瘤减灭术 早期诊断 概率

卵巢癌是妇科恶性肿瘤中发病率位居第三,死亡率位居第一的恶性肿瘤。因其深居盆腔,发病时约70%已达晚期,早期诊断较困难,晚期的治愈概率较小。晚期卵巢癌有广泛盆腹腔种植转移,传统的肿瘤细胞减灭术很难达到理想状态。因此,本文探讨术前化疗对晚期卵巢癌治疗价值。

Ovarian cancer is the third highest incidence of gynecological malignancies, the highest mortality rate of malignant tumors. Because of its deep pelvic cavity, about 70% of patients have reached the late onset, early diagnosis is more difficult, the probability of late cure is small. Late-stage ovarian cancer has extensive pelvic peritoneal metastasis, the traditional tumor cytoreductive surgery is difficult to achieve the desired state. Therefore, this article discusses the value of preoperative chemotherapy for the treatment of advanced ovarian cancer.